on SeedInvest
Home & GardenTech


Self-care AI med-tech platform and glucometer that enables people to manage their own diabetes.
Oak Park Heights, 
Investment type:
(Convertible Note)
Target raise:
Minimum investment:​
End date:
Jul 31, 2021
Share on facebook
Share on twitter
Share on linkedin
Share on email

Revenue generating contracts are in place, including with key strategics such as Zurich Insurance Group, MOBE for Life, and Nice Healthcare

Achieved over a 90% average month-over-month user growth for the first four months of 2021

FDA-approved product with 15 issued patents and 16 pending patents

Clinical data accepted for ADA 2021 publication demonstrating a sustained and significant 15% improvement in A1c (glucose control), even after 18 months of Pops use

Key investors include Revolution ROTR, 30 Ventures, and Flying Point. Award winning (2016 American Diabetes Association, 2018 Inventures) and chosen as a 2018 Pepperdine Most Fundable company